Application of Quality Risk Management in the Production Phase of Investigational Medicinal Products for Early Clinical Trials

Hao Xingping, Yang Shunfu, Sun Shuaijun, Zhao Fang, Du Lifang, Xu Jing

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (8) : 883-891.

PDF(981 KB)
PDF(981 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (8) : 883-891. DOI: 10.16153/j.1002-7777.2025-04-0045
Quality Management

Application of Quality Risk Management in the Production Phase of Investigational Medicinal Products for Early Clinical Trials

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(8): 883-891 https://doi.org/10.16153/j.1002-7777.2025-04-0045

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(981 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉